In This Article:
As global markets navigate a landscape of economic uncertainty and shifting policies, Asian stocks present intriguing opportunities for investors seeking value. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can be a prudent strategy to potentially capitalize on market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name | Current Price | Fair Value (Est) | Discount (Est) |
Consun Pharmaceutical Group (SEHK:1681) | HK$8.87 | HK$17.63 | 49.7% |
RACCOON HOLDINGS (TSE:3031) | ¥957.00 | ¥1890.86 | 49.4% |
Sichuan Kexin Mechanical and Electrical EquipmentLtd (SZSE:300092) | CN¥13.10 | CN¥25.69 | 49% |
TechnoPro Holdings (TSE:6028) | ¥3306.00 | ¥6593.98 | 49.9% |
S Foods (TSE:2292) | ¥2556.00 | ¥5084.09 | 49.7% |
Bide Pharmatech (SHSE:688073) | CN¥54.00 | CN¥106.91 | 49.5% |
Takara Bio (TSE:4974) | ¥866.00 | ¥1698.81 | 49% |
ALUX (KOSDAQ:A475580) | ₩11250.00 | ₩22243.70 | 49.4% |
Kinsus Interconnect Technology (TWSE:3189) | NT$93.10 | NT$182.94 | 49.1% |
Zhejiang Juhua (SHSE:600160) | CN¥24.28 | CN¥47.60 | 49% |
Below we spotlight a couple of our favorites from our exclusive screener.
Smoore International Holdings
Overview: Smoore International Holdings Limited is an investment holding company that provides vaping technology solutions and has a market cap of HK$83.08 billion.
Operations: The company generates revenue primarily from the sale of APV and vaping devices and components, amounting to CN¥11.80 billion.
Estimated Discount To Fair Value: 13.7%
Smoore International Holdings is trading at HK$13.66, below its estimated fair value of HK$15.83, suggesting potential undervaluation based on cash flows. Earnings are forecast to grow significantly at 24.94% annually, outpacing the Hong Kong market's growth rate. However, recent financial results show a decline in net income from CNY 1,645.09 million to CNY 1,303.26 million year-over-year despite increased sales revenue to CNY 11.80 billion from CNY 11.20 billion.
Ningbo Sanxing Medical ElectricLtd
Overview: Ningbo Sanxing Medical Electric Co., Ltd. manufactures and sells power distribution and utilization systems both in China and internationally, with a market cap of CN¥41.34 billion.
Operations: The company generates revenue from the manufacture and sale of power distribution and utilization systems, serving both domestic and international markets.